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ABSTRACT Mucosal immunity to the enteric pathogen Shigella ﬂexneri is mediated by secretory IgA (S-IgA) antibodies directed
againsttheO-antigen(O-Ag)sidechainoflipopolysaccharide.WhilesecretoryantibodiesagainsttheO-Agareknowntopre-
ventbacterialinvasionoftheintestinalepithelium,themechanismsbywhichthisoccursarenotfullyunderstood.Inthisstudy,
we report that the binding of a murine monoclonal IgA (IgAC5) to the O-Ag of S. ﬂexneri serotype 5a suppresses activity of the
type 3 secretion (T3S) system, which is necessary for S. ﬂexneri to gain entry into intestinal epithelial cells. IgAC5’s effects on the
T3Swererapid(5to15min)andwerecoincidentwithapartialreductioninthebacterialmembranepotentialandadecreasein
intracellularATPlevels.ActivityoftheT3Ssystemreturnedtonormallevels45to90minfollowingantibodytreatment,demon-
stratingthatIgAC5’seffectsweretransient.Nonetheless,thesedatasuggestamodelinwhichtheassociationofIgAwiththe
O-Ag of S. ﬂexneri partially de-energizes the T3S system and temporarily renders the bacterium incapable of invading intestinal
epithelialcells.
IMPORTANCE SecretoryIgA(S-IgA)servesastheﬁrstlineofdefenseagainstentericinfections.However,despiteitswell-
recognizedroleinmucosalimmunity,relativelylittleisknownatthemolecularlevelabouthowthisclassofantibodyfunctions
topreventpathogenicbacteriafrompenetratingtheepithelialbarrier.ItisgenerallyassumedthatS-IgAfunctionsprimarilyby
“immuneexclusion,”aphenomenoninwhichtheantibodybindstomicrobialsurfaceantigensandtherebypromotesbacterial
agglutination,entrapmentinmucus,andphysicalclearancefromthegastrointestinaltractviaperistalsis.Theresultsofthepres-
entstudysuggestthatinadditiontoservingasaphysicalbarrier,S-IgAmayhaveadirectimpactontheabilityofmicrobial
pathogenstosecretevirulencefactorsrequiredforinvasionofintestinalepithelialcells.
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S
higella ﬂexneri is the causative agent of bacillary dysentery, an
invasivediseaseofthecolonicmucosathatafﬂictsmorethana
million children each year (1). Like Salmonella and other related
Gram-negative bacterial pathogens, S. ﬂexneri penetrates intesti-
nal epithelial cells by virtue of a type 3 secretion (T3S) system, a
macromolecular protein transport apparatus that is structurally
and genetically related to bacterial ﬂagella (2). Upon contact with
epithelial cells, the T3S apparatus injects effector proteins, also
known as the invasion plasmid antigens (e.g., IpaB, IpaC, and
IpaD),intohostcells,resultingincytoskeletalrearrangementsand
bacterialmacropinocytosis.AssemblyandfunctionoftheT3Ssys-
tem are regulated in response to physical and environmental sig-
nalsthatthebacteriumencountersinthegastrointestinaltract(3,
4).
In humans, protective immunity to S. ﬂexneri is strongly cor-
related with secretory IgA (S-IgA) antibodies directed against the
serotype-speciﬁcO-antigen(O-Ag)sidechainsoflipopolysaccha-
ride (1, 5). In experimental models of shigellosis, it has been
shownthatpassivemucosaladministrationofamurinemonoclo-
nal dimeric/polymeric IgA (MAb) known as IgAC5, directed
against the O-Ag of S. ﬂexneri serotype 5a, is sufﬁcient to protect
otherwisenaiveanimalsagainstinfection(6,7).Protectionoccurs
at mucosal surfaces, as IgAC5-coated bacteria are demonstrably
lessinvasivethantheiruncoatedcounterparts(7).BecauseIgAC5
isneitherbactericidalnorbacteriostatic,IgAC5’sprotectiveeffects
have been attributed in part to the ability of the antibody to pro-
mote bacterial entrapment in mucus, a phenomenon known as
“immune exclusion” (7, 8). However, whether IgAC5 has addi-
tional effects on S. ﬂexneri that contribute to protection of intes-
tinal epithelial cells has not been determined.
Recent work from our laboratory has suggested that exposure
ofarelatedbacterium,SalmonellaentericaserovarTyphimurium,
toanO-Ag-speciﬁcIgAundernonagglutinatingconditionsissuf-
ﬁcient to prevent bacterial invasion of intestinal epithelial cells,
possiblythroughinterferencewiththeT3Ssystem(9,10).Forthis
reason,wesoughttoexaminetheimpactofIgAC5onT3Ssystem-
mediated export of Ipa proteins by S. ﬂexneri. Strain M90T (1 
109CFUperml)wastreatedwithIgAC5(2to5g/ml)for15min
priortobeingexposedtoCongored(CR),agratuitousinducerof
S.ﬂexneritype3-mediatedIpasecretion(11).Therewasamarked
OBSERVATION
May/June 2011 Volume 2 Issue 3 e00042-11
® mbio.asm.org 1reduction (90%) in IpaB levels in the supernatants of cultures
that had been treated with IgAC5 and CR, compared to superna-
tants from cells treated with CR only (Fig. 1A). Corresponding
analysis of total cell lysates revealed that, following IgAC5 treat-
ment, IpaB remained associated with the cell pellet (Fig. 1B). The
reduction in IpaB secretion by IgAC5 was roughly equivalent to
that achieved by treatment with the proton ionophore carbonyl
cyanide m-chlorophenylhydrazone (CCCP; Sigma-Aldrich, St.
Louis,MO)(Fig.1AandB,lane6).Surprisingly,however,wealso
noted that IpaB levels were markedly reduced (45%) upon ex-
posureofS.ﬂexneritoseveralisotypecontrolMAbs,likeTEPC-15
(Fig.1AandB,lane3).ThisresultsuggeststhatIgA,irrespectiveof
the variable region (Fv), interferes to some degree with T3S activ-
ity. This ﬁnding further expands a role for S-IgA in innate immu-
nity at mucosal surfaces and may explain the observation by Wi-
jburg and colleagues that T3S-mediated invasion of intestinal
epithelial cells by S. Typhimurium is suppressed ~5-fold by IgA
antibodies from naive mice (12, 13).
Therefore,todiscernthespeciﬁccontributionoftheantibody-
variable (Fv) region of IgAC5 on effector secretion by S. ﬂexneri,
IpaB levels were subsequently normalized to an isotype control
MAb. A dose-response experiment revealed that IgAC5 reduced
FIG 1 IgAC5 suppresses secretion of Ipa proteins by S. ﬂexneri. A total
of 1  109 CFU per ml of mid-log-phase cultures of S. ﬂexneri strain
M90T was treated with IgAC5, control IgA MAbs (e.g., TEPC-15 and
Sal4), O-Ag polyclonal rabbit antisera, or CCCP for the indicated times
prior to the addition of Congo red (CR; 6 g/ml) to trigger T3S system-
mediated Ipa transport. Ten minutes later, the bacterial cultures were
subjected to centrifugation (5 min at 8,000 relative centrifugal force
[RCF]). The resulting supernatants were passed through a 0.2-m ﬁlter
to remove any contaminating bacterial cells, concentrated with trichlo-
roacetic acid, solubilized in Laemmli sample buffer containing
-mercaptoethanol (-ME; 5% [vol/vol]), and then analyzed by SDS-
PAGE and Western blotting (W.B.) with murine IgG MAbs speciﬁc for
IpaB or IpaC (as indicated) and chemiluminescent detection (Bio-Rad,
Hercules,CA).TheamountofIpaBorIpaCwasdeterminedbydensito-
metric analysis of the Western blot ﬁlms. IpaB and IpaC amounts below
the level of detection were set to 1. For panel B only, the bacterial pellets
werelysedbytheadditionof2Laemmlisamplebufferwith-MEand
subjectedtoSDS-PAGEandWesternblotting,asindicatedabove.(Aand
B)Supernatants(A)orbacterialpellets(B)fromculturesweretreatedas
follows:lane1,notreatment;lane2,notreatmentfollowedbyCR;lane3,
TEPC-15 (5 g/ml) for 15 min followed by CR; lane 4, IgAC5 (2 g/ml)
for 15 min followed by CR; lane 5, IgAC5 (5 g/ml) for 15 min followed
by CR; lane 6, CCCP (100 M) for 15 min followed by CR. The relative
amounts of IpaB in the cell supernatants are indicated across the top of
thepanelas“%control.”Inthiscase,thecontrolwastheamountofIpaB
associatedwithCR-treatedcells(lane2).(C)Dose-dependentinhibition
ofIpaBsecretionbyIgAC5.ShownareIpaBlevelsinthesupernatantsof
cultures of S. ﬂexneri M90T treated for 15 min with the indicated con-
centrationsofIgAC5ortheS.Typhimurium-speciﬁcIgAMAbSal4prior
to the addition of CR. Cells treated with SalIV and CR (lane 5) served as
the positive control for this experiment, and the amounts of IpaB in the
supernatants are expressed as a percentage of this control. (D) IpaC
secretion is inhibited by O-Ag polyclonal antibodies (PAbs). Cultures of
S. ﬂexneri were treated with 2.5 or 5 g/ml O-Ag PAbs or CCCP
(100 M) for 15 min prior to the addition of CR. Culture supernatants
were prepared as indicated above and blotted with an IpaC-speciﬁc
MAb. The vertical line between lanes 2 and 3 indicates that a lane(s)
present in the original Western blot at this location was removed from
theﬁnalimage.Theremovedlane(s)representsexperimentalconditions
thatwerenotrelevanttotheﬁgure.(EtoF)IgAC5’seffectsonIpasecre-
tion are transient. Cultures of S. ﬂexneri were treated with IgAC5 (5 g/
ml),O-AgPAbs(5g/ml),orCCCP(100M)for45min(E)or90min
(F) prior to the addition of CR. Culture supernatants were then blotted
with an IpaB-speciﬁc MAb. The elevated levels of IpaB in the negative
control samples (lanes 1) in these experiments (compared to those de-
scribedinpanelsAtoD)reﬂectthebaselineaccumulationoftheproteins
inculturesupernatantsovertheprolongedcourseoftheexperiments(45
and 90 min in panels E and F, compared to 15 min for experiments
describedinpanelsAtoD).(G)Dose-dependentinhibitionofIpasecre-
tionbyCCCP.CulturesofS.ﬂexneriweretreatedwithindicatedconcen-
trations CCCP for 15 min prior to the addition of CR, after which cell
supernatants were blotted for IpaC.
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demonstrating the importance of O-Ag recognition in suppres-
sion of T3S activity (Fig. 1C). The contribution of the Fv region
was further underscored by the observation that IpaB secretion
into culture supernatants following CR treatment was reduced to
baseline levels in the presence of rabbit polyclonal O-Ag-speciﬁc
IgG antiserum (BD Diagnostic Systems, Sparks, MD) (Fig. 1D).
Interestingly, the inhibitory effects of both IgAC5 and polyclonal
O-Ag antiserum were transient, as secretion of IpaB levels re-
turned to normal 45 min after IgAC5 treatment (Fig. 1E and F,
lane 3) and ~90 min after polyclonal O-Ag antiserum exposure
(Fig.1EandF,lane4).TheprolongedblockingofIpasecretionin
the presence of antiserum might be due the diversity of epitopes
recognized by the IgG antibody molecules, as opposed to the sin-
gle epitope recognized by IgAC5.
The observation that exposure of S. ﬂexneri to IgAC5 resulted
inalossinT3Sactivityledustopostulatethatantibodybindingto
theO-Agmaypartiallyde-energizetheelectropotentialofthebac-
terial membrane. We were particularly interested in the effect of
IgAC5 on the proton motive force (PMF) and intracellular ATP
levels,becausethePMFand/orATPlevelshavebeenimplicatedin
poweringtheT3Smachineryinseveralenterobacteria(14–17).To
ﬁrst deﬁne the relationship between Ipa secretion and PMF in
S. ﬂexneri, we subjected bacterial cells to escalating doses of the
proton ionophore CCCP and then examined both IpaC secretion
and PMF. PMF, or more speciﬁcally the membrane potential
()componentofPMF,wasestimatedbyusingthecationicdye
JC-1 (Invitrogen, Carlsbad, CA), essentially as done previously
(18, 19). As expected, CCCP treatment resulted in a dose-
dependent reduction in CR-mediated IpaC secretion (Fig. 1G).
Correspondingly, CCCP treatment resulted in a time- and dose-
dependent decrease in membrane potential (Fig. 2A). ATP levels
also plummeted following CCCP treatment, although levels re-
covered with time, probably reﬂecting S. ﬂexneri’s capacity to re-
generate ATP in the absence of an intact PMF (Fig. 2B) (20).
Having established a correlation between S. ﬂexneri’s bioener-
geticstateandIpasecretion,wenextexaminedtheeffectofIgAC5
on PMF and ATP levels. We observed that treatment of S. ﬂexneri
with IgAC5 was accompanied by a dose- and time-dependent re-
duction in membrane potential (Fig. 2A). For example, exposure
of cells to 10 g/ml IgAC5 resulted in a reduction in  ranging
from25to40%andwasaccompaniedbyacoincidentdecrease(20
to 25%) in ATP levels (Fig. 2B), supporting our hypothesis that
IgAC5 affects the electropotential of the S. ﬂexneri cell envelope.
However, treatment of cells with 5 g/ml IgAC5 only marginally
reduced  (5 to 10%), despite the fact that 5 g/ml IgAC5 was
previously shown to be sufﬁcient to suppress Ipa secretion to vir-
tually undetectable levels (Fig. 1). We postulate that this apparent
inconsistency is due to the relatively high threshold required to
promote JC-1 aggregation inside cells (21) and the exquisite sen-
sitivityoftheIpaT3Ssystemtothephysiologicstateofthecell(3).
On the other hand, we cannot rule out the possibility that IgAC5
notonlyperturbsmembranepotentialbutalsointerfereswiththe
T3S system by an additional mechanism related to its ability to
physically associate with the O-Ag. Indeed, the observation that
1MCCCPreducedbacterialmembranepotentialby20%but
only reduced IpaC secretion by 50% (compare Fig. 1G and 2A)
reveals that bioenergetics alone may not explain IgAC5’s full im-
pact on T3S.
Although it remains unclear from this study exactly how the
association of IgAC5 with the O-Ag leads to alterations in Ipa
secretion and changes in membrane potential, there are signal
transduction pathways and mechanosensitive channels localized
in the periplasm and inner membrane dedicated to “sensing”
changesatthecellsurface(22,23).IgAC5,byvirtueofitsabilityto
bind and cross-link the O-Ag, may induce a type of outer mem-
brane “stress” that effectively destabilizes the outer leaﬂet of the
outer membrane (24). Triggering of membrane stress response
pathways (23) and/or mechanosensitive channels (22) could di-
rectlyorindirectlyimpactthePMFandactivityoftheT3Ssystem.
In support of an antibody-mediated membrane stress model, we
have recently described distinct ultrastructural changes in the
outermembraneofS.Typhimuriumassociatedwithexposuretoa
FIG 2 Reduction in S. ﬂexneri membrane potential and ATP levels following
IgAC5 treatment. (A) A total of 1  108 CFU of S. ﬂexneri SJF31 per ml was
loaded with the dye JC-1, seeded in 96-well microtiter plates, and then treated
withindicatedconcentrationsofIgAC5(g/ml)orCCCP(M).At2,15,and
30 min following IgAC5 or CCCP treatment, the relative ﬂuorescence emis-
sion signal ratios (530 nm/590 nm) were determined by using a Synergy HT
(Bio-Tek,Winooski,VT)ﬂuorescentplatereaderwithdualexcitation(485/20
and 530/25) and dual emission (528/20 and 590/35). The ﬂuorescence emis-
sion ratio of control cells was set to 100%. The results are the average values
(withstandarderror)fromarepresentativeexperimentdoneintriplicate.The
asterisks indicate a signiﬁcant (P  0.05) reduction in membrane potential
relative to the control samples, as determined by using the Student t test
(GraphPad Software, San Diego, CA). SJF31 (tolC::kan), an isogenic deriva-
tive of strain M90T, was created using  red-mediated recombination with
pKD4astheantibioticresistancemarkertemplate(26).Itwasnecessarytouse
a TolC mutant for these studies to avoid rapid expulsion of JC-1 from the cell
cytoplasm (24). (B) A total of 1  108 CFU of mid-log-phase S. ﬂexneri strain
M90T per ml grown in minimal medium with succinate (0.5%) as the sole
carbon source was treated with a phosphate-buffered saline (PBS), IgAC5
(10 g/ml), or CCCP (100 M). At the indicated time points, total cellular
ATP levels were measured with the BacTiter-Glo (Promega, Madison, WI)
luminescence assay. The asterisks indicate signiﬁcant (P  0.05) reduction in
ATP levels relative to the control samples, as determined by using the Student
t test.
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that IgAC5 treatment results in slightly elevated levels of the
periplasmic protein alkaline phosphatase (AP) in S. ﬂexneri cul-
turesupernatants(S.ForbesandN.Mantis,unpublishedresults),
consistent with antibody-induced alterations in outer membrane
integrityandleakageofperiplasmicproteinsintotheexternalme-
dium.
WhileIgAC5’seffectsonT3Sandbioenergeticswereonlytran-
sient, they could represent a signiﬁcant component of IgA-
mediated immunity to S. ﬂexneri at epithelial surfaces. We pro-
pose, for example, that IgAC5, upon ﬁrst encountering S. ﬂexneri
in vivo, may temporarily render the bacteria noninvasive. This
wouldthenenableantibody-mediatedagglutinationtotakeplace,
as well as subsequent entrapment of IgA-immune complexes in
mucus (8, 25). On another level, antibody-mediated damage to
theoutermembranecouldpotentiallymakeS.ﬂexnerisusceptible
to normally sublethal concentrations of antimicrobial factors
present in intestinal secretions, thereby providing a link between
the innate and adaptive immune systems at mucosal surfaces.
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